The Role of Lymphangiogenesis in Head and Neck Cancer Metastasis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2005 by National Taiwan University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00173381
First received: September 12, 2005
Last updated: March 29, 2006
Last verified: June 2005
  Purpose

The purpose of this study is to investigate the role of lymphangiogenesis in the metastasis of head and neck cancer.


Condition
Oral Cancer
Laryngeal Cancer
Hypopharyngeal Cancer

Study Type: Observational
Study Design: Allocation: Random Sample
Observational Model: Natural History
Time Perspective: Longitudinal

Resource links provided by NLM:


Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment: 100
Study Start Date: August 2004
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   30 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Head and neck squamous cell carcinoma

Exclusion Criteria:

  • Other pathological type
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00173381

Contacts
Contact: Ching-Ting Tan, MD, PhD 886-2-23123456 ext 5222 christin@ha.mc.ntu.edu.tw

Locations
Taiwan
National Taiwan University Hospital Recruiting
Taipei, Taiwan, 100
Contact: Ching-Ting Tan, MD, PhD    886-2-23123456 ext 5222    christin@ha.mc.ntu.edu.tw   
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Principal Investigator: Ching-Ting Tan, MD, PhD National Taiwan University Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00173381     History of Changes
Other Study ID Numbers: 9461700657
Study First Received: September 12, 2005
Last Updated: March 29, 2006
Health Authority: Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:
lymphangiogenesis
head and neck squamous cell carcinoma (HNSCC)
vascular endothelial growth factor-C (VEGF-C)
cyclooxygenase-2 (COX-2)
interleukin-6 (IL-6)

Additional relevant MeSH terms:
Hypopharyngeal Neoplasms
Pharyngeal Neoplasms
Otorhinolaryngologic Neoplasms
Head and Neck Neoplasms
Neoplasms by Site
Neoplasms
Pharyngeal Diseases
Stomatognathic Diseases
Otorhinolaryngologic Diseases

ClinicalTrials.gov processed this record on September 29, 2014